drugset / Trial / NCT03786302

Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth

NCT03786302

Phase 2 Terminated 102 enrolled Nourhan M.Aly Alexandria University · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study was to assess clinically, radiographically, and histologically the regenerative ability of Tailored Amorphous Mulioporous (TAMP-BG) bioglass in comparison to Biodentine™ (BD) in pulpotomized primary teeth.

Timeline

Start
2016-12-06
Primary completion
2018-08-15
Completion
2018-10-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Biodentine Other / unclassified
Subject TAMP bioglass Unknown

Indications